Skip to main content
Premium Trial:

Request an Annual Quote

Jack Secrist

Premium
The Southern Research Institute has named Jack Secrist CEO, effective Sept. 18.
 
Secrist has worked at SRI for 27 years, and has held the positions of COO, executive vice president, scientific director of life sciences, and most recently, vice president of drug discovery. He established a high-throughput screening facility at SRI’s Frederick, Md., facility, and eventually led its relocation to the institute’s main facility in Birmingham, Ala. He received a BS from the University of Michigan and a PhD from the University of Illinois. He was a National Institutes of Health post-doctoral fellow at Harvard University.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.